Skip Navigation

Frequent Questions A-Z Index

  
www.hhs.gov

Email Updates E-mail subscriptions envelope Font Size Reduce Text Size Enlarge Text Size     Print Print     Download Reader PDF

HHS Home > Blood Safety Home > Risk Assessments

Blood Safety Home

Biovigilance

Advisory Committee

National Blood Collection & Utilization Survey

Blood and Tissue Preparedness and Response

Risk Assessments

Archives

Contact Us

Risk Assessments

Potential risk of variant Creutzfeld-Jakob Disease (vCJD) in recipients of U.S. licensed plasma-derived products

Status of Immune Globulin Intravenous (IGIV) Products

HHS Home | Questions? | Contacting HHS | Accessibility | Privacy Policy | FOIA | Disclaimers | Plain Writing Act | No FEAR Act | Viewers & Players
The White House | USA.gov | Inspector General | PaymentAccuracy.gov | HHS Archive | Environmental Justice

U.S. Department of Health & Human Services - 200 Independence Avenue, S.W. - Washington, D.C. 20201